Literature DB >> 21186004

Glucose metabolism and neurological outcome in congenital hyperinsulinism.

Anja Ludwig1, Katja Ziegenhorn, Susann Empting, Thomas Meissner, Jan Marquard, Reinhard Holl, Klaus Mohnike.   

Abstract

Advances in imaging and surgical techniques allow a complete cure for children with focal-type congenital hyperinsulinism (CHI). In contrast, management of diffuse-type CHI remains a matter of controversy. To prevent hypoglycemic brain damage, extensive surgery has been recommended in the past, resulting in diabetes. On the basis of 2 data sets of patients with congenital hyperinsulinism, the German registry for CHI with 235 patients (ages 1 day to 19 years) and the diabetes treatment register (Diabetes Patienten-Verlaufsdokumentationssystem initiative), a follow-up study was initiated for diabetes mellitus and the intellectual and physical development as well as motor function. In our ongoing study, we investigated 20 patients with CHI (12 male, mean ages 9.9 years). Six of 20 patients had undergone subtotal pancreatectomy. In early infantile development (0-3 years) we observed a trend to motor and speech delay. In early childhood (2.5-7 years) there appeared a trend to an advantage of results of nonverbal tasks compared with verbal tasks. Before 1990 most patients (∼75%) were treated by subtotal pancreatectomy; since 2000, a more conservative approach is obvious (4/68). All patients with diabetes (n = 25) developed the condition after undergoing subtotal pancreatectomy. No spontaneous manifestation of diabetes was noted before adulthood. There was a wide range of age (0-17.7 years) at manifestation indicating a long period during which glucose tolerance is compensated. Compared with >40.000 children with type 1 diabetes mellitus from the Diabetes Patienten-Verlaufsdokumentationssystem registry, we found significant differences with a tendency for being overweight as well as small stature. Mean daily insulin dose and HbA1c was comparable in both groups. 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21186004     DOI: 10.1053/j.sempedsurg.2010.10.005

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  18 in total

Review 1.  Glycemic extremes in youth with T1DM: the structural and functional integrity of the developing brain.

Authors:  Ana Maria Arbelaez; Katherine Semenkovich; Tamara Hershey
Journal:  Pediatr Diabetes       Date:  2013-10-14       Impact factor: 4.866

2.  High Risk of Diabetes and Neurobehavioral Deficits in Individuals With Surgically Treated Hyperinsulinism.

Authors:  Katherine Lord; Jerilynn Radcliffe; Paul R Gallagher; N Scott Adzick; Charles A Stanley; Diva D De León
Journal:  J Clin Endocrinol Metab       Date:  2015-09-01       Impact factor: 5.958

3.  Persistent hyperinsulinemic hypoglycemia of infancy: a clinical and pathological study of 19 cases in a single institution.

Authors:  Jiwei Li; Yangyang Ma; Mengxing Lv; Jun Zhou; Baihui Liu; Kuiran Dong; Xianmin Xiao; Lian Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  Focal form of congenital hyperinsulinism clearly detectable by contrast-enhanced computed tomography imaging.

Authors:  Yukiko Hashimoto; Azumi Sakakibara; Rie Kawakita; Yuki Hosokawa; Rika Fujimaru; Tetsuro Nakamura; Hiroko Fukushima; Aiko Igarashi; Michiya Masue; Hironori Nishibori; Nobuyoshi Tamagawa; Akiko Murakami; Kazue Hatake; Tohru Yorifuji
Journal:  Int J Pediatr Endocrinol       Date:  2015-09-15

5.  Pancreatic endocrine and exocrine function in children following near-total pancreatectomy for diffuse congenital hyperinsulinism.

Authors:  Ved Bhushan Arya; Senthil Senniappan; Huseyin Demirbilek; Syeda Alam; Sarah E Flanagan; Sian Ellard; Khalid Hussain
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

6.  Both Low Blood Glucose and Insufficient Treatment Confer Risk of Neurodevelopmental Impairment in Congenital Hyperinsulinism: A Multinational Cohort Study.

Authors:  Annett Helleskov; Maria Melikyan; Evgenia Globa; Inna Shcherderkina; Fani Poertner; Anna-Maria Larsen; Karen Filipsen; Klaus Brusgaard; Charlotte Dahl Christiansen; Lars Kjaersgaard Hansen; Henrik T Christesen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-10       Impact factor: 5.555

Review 7.  Congenital Hyperinsulinism: Diagnosis and Treatment Update.

Authors:  Hüseyin Demirbilek; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-27

8.  Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital Hyperinsulinism.

Authors:  Hima Bindu Avatapalle; Indraneel Banerjee; Sajni Shah; Megan Pryce; Jacqueline Nicholson; Lindsey Rigby; Louise Caine; Mohammed Didi; Mars Skae; Sarah Ehtisham; Leena Patel; Raja Padidela; Karen E Cosgrove; Mark J Dunne; Peter E Clayton
Journal:  Front Endocrinol (Lausanne)       Date:  2013-05-20       Impact factor: 5.555

Review 9.  Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management.

Authors:  Zainaba Mohamed; Ved Bhushan Arya; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-10-02

Review 10.  Congenital hyperinsulinism: current status and future perspectives.

Authors:  Tohru Yorifuji
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.